Results 251 to 260 of about 537,637 (340)

Stiripentol use in Dravet syndrome patients in the USA: Results of a real‐world study

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Dravet syndrome (DS) is a severe developmental and epileptic encephalopathy with a high seizure burden and mortality risk. Stiripentol, one of the first DS‐specific therapies, received FDA approval in 2018 but its real‐world use and impact post‐approval in the USA remain insufficiently characterized.
Elaine Wirrell   +11 more
wiley   +1 more source

Bronchiectasis, Low IgG Levels and Lack of Vaccination are Risk Factors for Covid-19 Hospitalization in X-linked Agammaglobulinemia - A Retrospective Multicenter Study. [PDF]

open access: yesJ Clin Immunol
Stenlander C   +26 more
europepmc   +1 more source

Development of ambulatory fall monitor for the elderly

open access: bronze, 2000
Takumi Yoshimura   +6 more
openalex   +2 more sources

Rapid recovery after intrathecal dexamethasone in FIRES

open access: yes
Epileptic Disorders, EarlyView.
João Filipe Nico   +8 more
wiley   +1 more source

Tracking Glucose Trends, Unveiling Clinical Patterns: Insights From Continuous Glucose Monitoring in Patients at the Extreme of BMI and Eating Disorders Psychopathology

open access: yesEuropean Eating Disorders Review, EarlyView.
ABSTRACT Objective Disturbances of glucose homoeostasis are claimed to act as both a consequence and maintaining factor in eating disorders (EDs). This study explored glucose trends and their association with real‐time food intake and self‐report eating psychopathology in a sample of patients with anorexia nervosa (AN) and binge‐eating disorder (BED ...
Marianna Rania   +8 more
wiley   +1 more source

Hypotensive episodes at 24-h Ambulatory Blood Pressure Monitoring predict adverse outcomes in Parkinson’s Disease [PDF]

open access: gold
Fabrizio Vallelonga   +12 more
openalex   +1 more source

Do Prices Matter for Healthcare Accessibility? Evidence From a Means‐Tested Complementary Health Insurance in France

open access: yesHealth Economics, EarlyView.
ABSTRACT In France, the Couverture Maladie Universelle Complémentaire (CMU‐C) scheme is a means‐tested, state‐financed, complementary health insurance program that fully covers healthcare. Using administrative claims data and a staggered difference‐in‐differences approach, we estimate the impact of enrollment in the program on healthcare utilization ...
Benoît Carré   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy